Huub Schellekens – Studium Generale Universiteit Utrecht
PDF) Challenges in standardizing safety assessments of biopharmaceuticals, the case of EPREX Associated Pure Red Cell Aplasia | Toine Pieters - Academia.edu
Zomerportret 1. Huub Schellekens: 'Iedereen moet weer gaan doen waar hij goed in is' | medischcontact
SciELO - Saúde Pública - Hubs to spread technology and save lives Hubs to spread technology and save lives
eLearning module: The analytics – Biosimilars: From concern to confidence
Huub Schellekens's research works | Utrecht University, Utrecht (UU) and other places
Immunogenicity and glycosylation: The key issues for biosimilars - ppt video online download
Zomerportret 1. Huub Schellekens: 'Iedereen moet weer gaan doen waar hij goed in is' | medischcontact
PDF) Immunogenicity of mAbs in non-human primates during nonclinical safety assessment | Beatriz Silva Lima - Academia.edu
Evaluation of the suitability of a Sprague Dawley rat model to assess intravenous iron preparations
Impact of Biosimilar Insulins on Clinical Practice
Huub Schellekens, Professor of pharmaceutical biotechnology at Utrecht University: "We need 20 billion doses for the entire world population"
Huub Schellekens | European Association of Hospital Pharmacists
BIOLOGICALS UIT DE BIO-NESPRESSO?
Immunogenicity and aggregation of therapeutic proteins - American ...
PDF) Immunogenicity of Recombinant Human Interferon Beta-1b in Immune-Tolerant Transgenic Mice Corresponds with the Biophysical Characteristics of Aggregates
Huub Schellekens | Writers Unlimited
Dure medicijnen mogelijk betaalbaar door Utrechtse uitvinding | De Utrechtse Internet Courant
Catalogus Professorum - Prof Detail
Huub Schellekens, Professor of pharmaceutical biotechnology at Utrecht University: "We need 20 billion doses for the entire world population"
Opgestapt CBG-lid Huub Schellekens uit forse kritiek op 'de perversies van het systeem' - HUMAN - VPRO
Huub Schellekens - HR Business Partner - Feenstra | LinkedIn
Zo kan Nederland zich beter wapenen tegen epidemieën
Heidi Schellekens - massage & bewustwording Utrecht | Utrecht
PDF) Making individualized drugs a reality
Pharmaceutical Technology Europe - August 2010 - What is Hindering the Uptake of Biosimilars
